Ignite Creation Date:
2025-12-24 @ 6:33 PM
Ignite Modification Date:
2026-01-28 @ 4:53 PM
Study NCT ID:
NCT04750057
Status:
NO_LONGER_AVAILABLE
Last Update Posted:
2021-05-06
First Post:
2021-02-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Anifrolumab Early Access Program
Sponsor:
AstraZeneca
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Systemic Lupus Erythematosus | View |
Keywords: